INDOCO REMEDIES
Back to Balance Sheet
|
INDOCO REMEDIES Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹808 Cr | ₹645 Cr | ₹481 Cr | ₹518 Cr | ₹407 Cr |
What is the latest Total Current Liabilities ratio of INDOCO REMEDIES ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹808 Cr |
| Mar2024 | ₹645 Cr |
| Mar2023 | ₹481 Cr |
| Mar2022 | ₹518 Cr |
| Mar2021 | ₹407 Cr |
How is Total Current Liabilities of INDOCO REMEDIES Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹808 Cr | 25.25 | |
| Mar2024 | ₹645 Cr | 34.26 | |
| Mar2023 | ₹481 Cr | -7.21 | |
| Mar2022 | ₹518 Cr | 27.34 | |
| Mar2021 | ₹407 Cr | - | |
Compare Total Current Liabilities of peers of INDOCO REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDOCO REMEDIES | ₹1,985.5 Cr | -2.2% | -8.3% | -15.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹386,341.0 Cr | -1.8% | -6.4% | -10.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹160,401.0 Cr | -0.3% | -5.5% | 8.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹135,175.0 Cr | -0.1% | 4% | 18.7% | Stock Analytics | |
| CIPLA | ₹107,100.0 Cr | 1% | -12.3% | -5.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,715.9 Cr | -4.6% | -7% | 1.8% | Stock Analytics | |
INDOCO REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDOCO REMEDIES | -2.2% |
-8.3% |
-15.6% |
| SENSEX | -1% |
-4.7% |
6% |
You may also like the below Video Courses